BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 25087218)

  • 1. [New methods in the treatment of localized prostate cancer: use of dynamic arc therapy and kV cone-beam CT positioning].
    Szappanos S; Farkas R; Lőcsei Z; László Z; Kalincsák J; Bellyei S; Sebestyén Z; Csapó L; Sebestyén K; Halász J; Musch Z; Beöthe T; Farkas L; Mangel L
    Orv Hetil; 2014 Aug; 155(32):1265-72. PubMed ID: 25087218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer.
    Akino Y; Koizumi M; Sumida I; Takahashi Y; Ogata T; Ota S; Isohashi F; Konishi K; Yoshioka Y
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1715-22. PubMed ID: 21620584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
    Qin A; Sun Y; Liang J; Yan D
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.
    Zelefsky MJ; Kollmeier M; Cox B; Fidaleo A; Sperling D; Pei X; Carver B; Coleman J; Lovelock M; Hunt M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):125-9. PubMed ID: 22330997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on planning organ at risk volume for the rectum using cone beam computed tomography in the treatment of prostate cancer.
    Prabhakar R; Oates R; Jones D; Kron T; Cramb J; Foroudi F; Geso M; Gill S
    Med Dosim; 2014; 39(1):38-43. PubMed ID: 24412028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional conformal arc radiotherapy using a C-arm linear accelerator with a computed tomography on-rail system for prostate cancer: clinical outcomes.
    Kumabe A; Fukuhara N; Utsunomiya T; Kawase T; Iwata K; Okada Y; Sutani S; Ohashi T; Oya M; Shigematsu N
    Radiat Oncol; 2015 Oct; 10():208. PubMed ID: 26458948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy.
    Pasquier D; Cavillon F; Lacornerie T; Touzeau C; Tresch E; Lartigau E
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):549-54. PubMed ID: 22677369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
    Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
    Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of daily imaging on plan quality and normal tissue toxicity for prostate cancer radiotherapy.
    Bell K; Heitfeld M; Licht N; Rübe C; Dzierma Y
    Radiat Oncol; 2017 Jan; 12(1):7. PubMed ID: 28069053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experience in image-guided ultra-conformal hypofractionated radiotherapy in case of metastatic diseases at the University of Pécs].
    László Z; Boronkai Á; Lõcsei Z; Kalincsák J; Szappanos S; Farkas R; Al Farhat Y; Sebestyén Z; Sebestyén K; Kovács P; Csapó L; Mangel L
    Magy Onkol; 2015 Jun; 59(2):154-9. PubMed ID: 26035164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy.
    Smeenk RJ; van Lin EN; van Kollenburg P; Kunze-Busch M; Kaanders JH
    Radiother Oncol; 2009 Oct; 93(1):131-6. PubMed ID: 19523704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Dosimetric Comparison between Conventional Fractionated and Hypofractionated Image-guided Radiation Therapies for Localized Prostate Cancer.
    Li M; Li GF; Hou XY; Gao H; Xu YG; Zhao T
    Chin Med J (Engl); 2016 Jun; 129(12):1447-54. PubMed ID: 27270540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of intensity-modulated radiation therapy for prostate cancer: History, clinical results and future directions.
    Hatano K; Tohyama N; Kodama T; Okabe N; Sakai M; Konoeda K
    Int J Urol; 2019 Aug; 26(8):775-784. PubMed ID: 31115116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-pelvic volumetric-modulated arc therapy for high-risk prostate cancer: treatment planning and acute toxicity.
    Ishii K; Ogino R; Hosokawa Y; Fujioka C; Okada W; Nakahara R; Kawamorita R; Tada T; Hayashi Y; Nakajima T
    J Radiat Res; 2015 Jan; 56(1):141-50. PubMed ID: 25304328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of a soft tissue-based setup using cone-beam computed tomography over a bony structure-based setup in intensity-modulated radiotherapy for prostate cancer.
    Sato H; Abe E; Utsunomiya S; Kaidu M; Yamana N; Tanaka K; Ohta A; Obinata M; Liu J; Kawaguchi G; Maruyama K; Ayukawa F; Aoyama H
    J Appl Clin Med Phys; 2015 Sep; 16(5):239–245. PubMed ID: 26699304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
    Ghilezan M; Yan D; Liang J; Jaffray D; Wong J; Martinez A
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1602-10. PubMed ID: 15590192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyses of the factors influencing the accuracy of three-dimensional ultrasound in comparison with cone-beam CT in image-guided radiotherapy for prostate cancer with or without pelvic lymph node irradiation.
    Zhou S; Luo L; Li J; Lin M; Chen L; Shao J; Lu S; Ma Y; Zhang Y; Chen W; Liu M; Liu S; He L
    Radiat Oncol; 2019 Jan; 14(1):22. PubMed ID: 30696488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis.
    Tamihardja J; Schortmann M; Lawrenz I; Weick S; Bratengeier K; Flentje M; Guckenberger M; Polat B
    Strahlenther Onkol; 2021 Feb; 197(2):124-132. PubMed ID: 32833036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.